CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
Kronos Electrocautery Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05593211
NCT05593211N/ACompleted

Feasibility Study of the Kronos Electrocautery Device

Single Pass Inc·interventional·Posted Oct 25, 2022·Updated Jun 27, 2023

In Brief

A clinical study evaluating Kronos Electrocautery Device for Hepatic Disease and Renal Disease. Completed, enrolled 31 participants across 1 site.

Detailed Summary

The primary objective for this study is to assess safety and performance of the Kronos Electrocautery Device for electrocautery procedures following coaxial biopsy procedures on areas that include, but are not limited to, liver, kidney, lungs, breasts, soft tissue, etc.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedOct 25, 2022
Enrollment StartOct 17, 2022
Primary CompletionFeb 9, 2023
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.7 years ago

Interventions

Kronos Electrocautery Devicedevice

The Kronos Electrocautery Device is a disposable electrocautery device that can cauterize deep tissue through a standard biopsy procedure guide needle. This device is intended to coagulate the tissue surrounding the core biopsy channel during withdrawal to reduce or eliminate significant post-procedural bleeding. Currently, the Kronos Electrocautery Device consists of one (1) size. As such, the existing Kronos Electrocautery Device is chosen as the worst-case condition